Submitted by Anonymous (not verified) on 13 October 2023 - 9:56
Human medicines European public assessment report (EPAR): Wegovy , semaglutide, Obesity;Overweight, Date of authorisation: 06/01/2022, Revision: 4, Status: Authorised
Source: